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Background: The dose-response relationship is a fundamental pharmacological parameter necessary to determine
therapeutic thresholds. Epi-allelic hypomorphic analysis using RNA interference (RNAi) can similarly correlate target
gene dosage with cellular phenotypes. This however requires a set of RNAi triggers empirically determined to
attenuate target gene expression to different levels.
Results: In order to improve our ability to incorporate epi-allelic analysis into target validation studies, we
developed a novel flow cytometry-based functional screening approach (CellSelectRNAi) to achieve unbiased
selection of shRNAs from high-coverage libraries that knockdown target gene expression to predetermined levels.
Employing a Gaussian probability model we calculated that knockdown efficiency is inferred from shRNA sequence
frequency profiles derived from sorted hypomorphic cell populations. We used this approach to generate a
hypomorphic epi-allelic cell series of shRNAs to reveal a functional threshold for the tumor suppressor p53 in
normal and transformed cells.
Conclusion: The unbiased CellSelectRNAi flow cytometry-based functional screening approach readily provides an
epi-allelic series of shRNAs for graded reduction of target gene expression and improved phenotypic validation.Background
Delineating gene function relies on the genetic principle
established by decades of genetic mapping that mutations
establish causality in phenotypes. Trans-dominant genetic
effectors such as small molecule inhibitors and small inter-
fering RNA (siRNA) that alter the expression and function
of specific genes and proteins in trans, have dramatically
enhanced our ability to correlate the extent of cell behav-
ioral changes with the perturbation of gene expression and
function. Pharmacological dose response studies correlate
the degree of compound-induced inhibition of protein
function with cellular responses. Similarly, hypomorphic
alleles, mimicked by RNAi, have served as valuable tools
for deciphering the roles of various genes in cell function
[1,2]. Such epi-allelic hypomorphic analysis using different
RNAi triggering sequences empirically determined to* Correspondence: jim.lorens@biomed.uib.no
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unless otherwise stated.knockdown gene expression to distinct levels, provides a
unique opportunity to correlate gene expression levels
with phenotypic outcome [3]. Hence, epi-allelic analysis
can provide a dose response profile for putative thera-
peutic targets in lieu of small molecule inhibitors.
In order to improve our ability to conduct epi-allelic
analysis, we developed a robust flow cytometry-based func-
tional screening approach to enable unbiased selection of
shRNAs that generate graded knockdown of target gene
expression to predetermined levels. This genetic dose-re-
sponse can be used to validate candidate drug targets and
predict in vivo responses to inhibitor compounds.
Methods
Cell culture
All cells were cultured in a humidified atmosphere at 37°C
with 5% CO2. Phoenix A retroviral packaging cells (Dr.
Garry Nolan, Stanford University, USA) and MDA-MB-231
cells (ATCC) were maintained in DMEM (Gibco) and
F-12 K nutrient mixture (Kaighn’s modification) respectively,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(EuroClone, Italy), 2 mM L-glutamine, 100 U/ml penicillin
and 100 μg/ml streptomycin (all from Sigma-Aldrich) [4].
Leukemic cell line HL60 (gift from Dr. Bjørn T. Gjertsen;
University of Bergen, Norway) were cultured in Iscoves
medium containing 10% FBS, antibiotics and glutamine
(Sigma-Aldrich) [5]. Primary human umbilical vein en-
dothelial cells (HUVEC) (C2517A, Lonza, Switzerland)
were maintained in the supplier’s recommended complete
medium (EGM-2).
Retroviral transductions
Phoenix A cells were transfected using the calcium phos-
phate method [4]. Approximately 30 h after transfection,
the medium was changed to the appropriate growth
medium for the cells to be infected. Infectious supernatant
was harvested 48 h after transfection. Target cells were
spin-infected in virus-containing supernatant supplemen-
ted with 5 μg/ml protamine sulfate for 90 min at 1200 × g,
and then incubated overnight before being returned to
regular growth medium. Infected cells were selected with
1 μg/ml puromycin for 48 h.
Immunostaining and flow cytometry
The MDA-MB-231 cells were trypsinized using standard
procedures and washed with 0.2% BSA/PBS. Cells were
stained with anti-Axl antibody (MAB154; R&D Systems,
USA) at a final concentration of 2 μg/ml in 0.2% BSA/
PBS for 40 min. at room temperature. The cells were
then washed twice in 0.2% BSA/PBS and incubated with
secondary antibody (goat anti-mouse allophyocyanin-
crosslinked; Molecular Probes, USA) at a final concen-
tration of 0.2 μg/ml for 30 min. at room temperature in
the dark. The cells were washed twice with 0.2% BSA/
PBS and resuspended in 300 μl of 0.2% BSA/PBS before
analysis on a FACSAria cell sorter (BD Biosciences, USA).
Data analyses were carried out with FlowJo software (Tree
Star, USA).
Constructs
Functional shRNAs that were identified from the library
screen, were recloned into a new vector. The shRNAs
were expressed from a modified human U6 promoter
in the LTR of the retroviral vectors RRI-Red/L087
(GenBank: EU424173). For sequence information on
shAxl2, shAxl278, shAxl279, shAxl280 and shLuc see [2].
The retroviral expression vector pCSI expresses a
puromycin-N-acetyl-transferase-EGFP and firefly lucif-
erase cassette (Puro2A- GFP2ALuc2), with each open-
reading frame separated by a linker encoding the 2A
region (XXSGLRSGQLLNFDLLKLAGDVES- NPGP)
from foot-and-mouth disease virus for stoichiometric
co-translational polyprotein cleavage [6].Construction of the reporter gene vector
Reporter constructs were made by cloning the target
cDNA (Axl: 2.9 kb EcoRI/BamHI fragment from IMAGE
cDNA clone 5205825; p53: 1.5 kb PshA1/NotI fragment
from pSVp53 (gift from B.T. Gjertsen) into the 3′-un-
translated region of retroviral vector L101 (Complete
sequence in Additional file 1: Figure S1).
shRNA library construction
The construction of the Axl library has been described
previously [2]. The p53 library (p53 cDNA kindly provided
by BT Gjertsen, University of Bergen) was produced by a
new method (see Additional file 2: Figure S2), generating
a larger number of longer hairpins. p53 cDNA was frag-
mented with each of the following frequently-cutting
enzymes: HpaII/Hin6I (mixed), AluI, DpnI, BsuRI, RsaI,
HpyCH4V and blunt-ended with Klenow. The fragments
in each digestion mix were then capped at each end by
ligation with excess Hairpin oligo DK540 (PhoCTGCTG
GATCCAGAGACTCCAGAATTGTGAGCGCTCACAA
TTCTGGAGATGAGCCTTCGGTCTCATCTCTGGAT
CCAGCAG). PvuII and an appropriate frequent-cutter
enzyme were added to each mixture to inhibit unwanted
side reactions. After overnight ligation, reactions were
pooled, phenol extracted, chloroform extracted and size-
selectively precipitated with 15% PEG 8000/0.1 M MgCl2/
20 μg glycogen to get rid of excess DK540 [7,8] Hairpin
structures comprising 27 nt of p53-derived sequence
joined to hairpin oligo DK540 were released from each
end of the capped fragments by digestion with EcoP15I,
dephosphorylated with Antarctic Phosphatase (NEB) and
cleaned up by phenol/chloroform extraction and ethanol
precipitation. Following blunt-ending with Klenow the
hairpin loops (apparent MW approx 80 bp) were run on a
2% agarose/5 mM sodium borate gel [9] and purified by
electroelution onto GF/C paper (Whatman).
The hairpins were cloned and converted into hairpin
expression cassettes in a single step: Dephosphorylated hair-
pins were ligated to NaeI/NarI-cut L267 pEntr-U6NaeIXcmI,
a kanamycin resistant derivative of pDONR221 carrying a
PacI-U6 promoter-Termination signal-HindIII cassette,
and then cut with XcmI. The relatively small size of this
vector compared to retroviral vector L087 simplifies the
cloning and gives improved transformation efficiencies.
The product of ligation contains a nick at the 5′ end of
the hairpin due to the lack of 5′ phosphate. Extension
from the free 3′OH at this nick with a strand-displacing
polymerase (Klenow) opens out the hairpin structure into
dsDNA and at the same time removes the single nucleo-
tide 3′ XcmI overhang. The construct was then recir-
cularised and electroporated into competent cells and
plated. This primary library (many thousand colonies) was
scraped up and plasmid DNA isolated. The size of the
hairpin loop was reduced by digestion with GsuI, blunt-
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re-cloning. Finally, the complete U6:hairpin:termination
signal cassette was transferred into retroviral vector L297,
a slight modification of vector L087. Restriction enzymes
and polymerases were from New England Biolabs or
Fermentas.
Isolation of p53 targeting shRNAs
To select shRNAs that target human p53 mRNA from
the approximately 100 unique shRNA sequences, we
prepared virus supernatants from the p53 shRNA library
and control shLuc vectors as described above. Three
independent populations of 2 × 105 HL60 RNAi p53
reporter cells were infected with virus at a transduction
efficiency below 10% to ensure favor single retroviral inte-
grations per cell, with approximately 200 independent in-
tegrations per shRNA contstruct. After 48 h of Puromycin
selection and another 2 days of culture, mCherry positive
(as a marker for library infected cells) cells displaying
reduced GFP levels were sorted using a FACSAria cell
sorter. One hundred cells per well were sorted directly
into a 96-well PCR microplate (FS-C, Axygen Bioscienes)
containing 10 μl 1× Thermopol buffer/proteinase K
(100 μg/ml) (Sigma-Aldrich) per well. After sorting,
the PCR plate was incubated for 30 min at 37°C, and then
the enzyme was inactivated at 95°C for 10 min. Each well
was added 10 μl 2× PCR mix (see below) to a final volume
of 20 μl.
Amplification of shRNA pools from sorted cells
PCR mixture
The PCR mixture for amplifying vector genomic DNA
in a total volume of 20 μl contained 1.3 U and 0.1 U of
Taq/Pfu DNA Polymerase (Fermentas), 1× Thermopol
buffer (containing 20 mM of Tris–HCl (pH 8.8), 10 mM
of KCl, 10 mM of (NH4) 2SO4, 2 mM of MgSO4, 0.1%
of Triton X-100) (NEB), 0.25 μM of each primer,
0.375 mM dNTP mix (Fermentas). The reaction mixture
for the second amplification round was the same as for
the first one, except that 0.5 μM of the “inner” primers
with tags were used instead of the “outer” primers. In
the second amplification 2 μl of the first round PCR
product was used and the reaction was also supple-
mented with 2.5 mM MgCl2. See Table 1 for primer
information.
Nested PCR
PCR thermal cycles were carried out using a thermal
cycler (PTC-100, MJ Research) to amplify vector genomic
DNA using the following sequences: preheat at 95°C for
5 min; 35 cycles of 95°C for 30 s, 58°C for 20 s and 72°C
for 40 s. After 35 cycles of first round PCR, the second
round PCR thermal cycles were performed: preheat at
95°C for 2 min; 20 cycles of 95°C for 20 s, 56°C for20 s and 72°C for 30 s; additional extension at 72°C
for 5 min to end the amplification for both programs.
DNA was analyzed by 2% agarose gel electrophoresis and
stained by ethidium bromide. 9 μl of each nested PCR
were pooled, run on agarose gel and the PCR band
(ca. 280 nt) was purified with Illustria GFX PCR DNA
and gel band purification kit (GE Healthcare) before 454
sequencing (Roche) at The Norwegian High-Throughput
Sequencing Centre (University of Oslo).
454 sequence data analysis
Raw FASTA format 454 sequence data were analysed
using a series of simple Perl scripts (D. Micklem, unpub-
lished). Initially, the sequences were scanned to deter-
mine orientation (sequencing off A or B-primer) and to
identify the multiplex tag associated with each primer.
Primer and constant vector sequences were then deleted
and empty/too short sequences excluded. Remaining se-
quences were tested to determine whether they encoded
a hairpin structure. Finally, the sequences were clustered
into groups of near-identical sequences and the number
of times each sequence was seen in each tag-group was
tabulated.
Immunoblotting
Cells were lysed in RIPA buffer (25 mM Tris-HCl
pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycho-
late, 0.1% SDS) supplemented with protease inhibitor
(13457200; Roche). After addition of lysis buffer, the ex-
tract was incubated for 5 min on ice, and then passed
through a 29 gauge syringe. The suspension was centri-
fuged for 10 min at 10000 rpm and the supernatant pro-
tein concentration was measured using a BCA protein
assay kit (#23227, Pierce). SDS/PAGE (Novex NuPAGE
Bis-Tris 4-12% gels and MES buffer) and protein transfer
were carried out according to standard procedures given
by the manufacturer (Life Technologies). 20 μg protein
was loaded on the gel. Western blots were developed
with ECL substrate (#32106, Pierce) and the signal was
detected and analyzed using the BioRad ChemiDoc
XRS + system. p53 was detected using mouse monoclonal
anti-human p53 antibody (ab1101, Abcam) and Glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH) loading
control was detected with Millipore MAB379 antibody
(clone 6C5). Secondary antibody Goat anti-mouse (GAM)
IgG HRP (#G21040, Invitrogen).
Intensity of individual bands was quantified using ImageJ
densitometry software, andexpressed relative to GAPDH
signal, as a measure of protein relative abundance in the
different samples.
Irradiation
L108 Luc, shp53-3, shp53-10 and shp53-13 HUVEC
cells were harvested by trypsination and replated in
Table 1 Primers used in the amplification of shRNA pools from sorted cell
Primer sequence Id Info
CCGAGGTGGGCAGTCAATCAATCT DK633outerr outer primer
ACGCCATTTTGCAAGGCAT DK637altouterf outer primer
454-adaptor primers
Lowercase letters provide a multiplexing code to allow separate PCR reactions to be pooled and sequenced together
GCCTCCCTCGCGCCATCAGagcTTTCTTGGGTAGTTTGCAGTTT DK621ACodeAGC ‘A’ type, nested
GCCTCCCTCGCGCCATCAGtgaTTTCTTGGGTAGTTTGCAGTTT DK621ACodeTGA ‘A’ type, nested
GCCTCCCTCGCGCCATCAGcagTTTCTTGGGTAGTTTGCAGTTT DK621ACodeCAG ‘A’ type, nested
Type A primers are identical except for the 3 nt’s in small letters
GCCTTGCCAGCCCGCTCAGtactgacTTGTACAAGAAAGCTGGGTAAG DK622BCodeTActgaC ‘B’ type, nested
GCCTTGCCAGCCCGCTCAGtacgatcTTGTACAAGAAAGCTGGGTAAG DK622BCodeTAcgatC ‘B’ type, nested
GCCTTGCCAGCCCGCTCAGtacagtcTTGTACAAGAAAGCTGGGTAAG DK622BCodeTAcagtC ‘B’ type, nested
GCCTTGCCAGCCCGCTCAGtagactcTTGTACAAGAAAGCTGGGTAAG DK622BCodeTAgactC ‘B’ type, nested
GCCTTGCCAGCCCGCTCAGtagcatcTTGTACAAGAAAGCTGGGTAAG DK622BCodeTAgcatC ‘B’ type, nested
GCCTTGCCAGCCCGCTCAGtacgtacTTGTACAAGAAAGCTGGGTAAG DK622BCodeTAcgtaC ‘B’ type, nested
GCCTTGCCAGCCCGCTCAGtagctacTTGTACAAGAAAGCTGGGTAAG DK622BCodeTAgctaC ‘B’ type, nested
GCCTTGCCAGCCCGCTCAGtagtcacTTGTACAAGAAAGCTGGGTAAG DK622BCodeTAgtcaC ‘B’ type, nested
GCCTTGCCAGCCCGCTCAGcactgagTTGTACAAGAAAGCTGGGTAAG DK622BCodeCActgaG ‘B’ type, nested
GCCTTGCCAGCCCGCTCAGcacgatgTTGTACAAGAAAGCTGGGTAAG DK622BCodeCAcgatG ‘B’ type, nested
GCCTTGCCAGCCCGCTCAGcacagtgTTGTACAAGAAAGCTGGGTAAG DK622BCodeCAcagtG ‘B’ type, nested
GCCTTGCCAGCCCGCTCAGcagactgTTGTACAAGAAAGCTGGGTAAG DK622BCodeCAgactG ‘B’ type, nested
GCCTTGCCAGCCCGCTCAGcagcatgTTGTACAAGAAAGCTGGGTAAG DK622BCodeCAgcatG ‘B’ type, nested
GCCTTGCCAGCCCGCTCAGcacgtagTTGTACAAGAAAGCTGGGTAAG DK622BCodeCAcgtaG ‘B’ type, nested
GCCTTGCCAGCCCGCTCAGcagatcgTTGTACAAGAAAGCTGGGTAAG DK622BCodeCAgatcG ‘B’ type, nested
GCCTTGCCAGCCCGCTCAGcagtcagTTGTACAAGAAAGCTGGGTAAG DK622BCodeCAgtcaG ‘B’ type, nested
Type B primers are identical except the 7 nt’s in small letters.
Table 2 Gene expression assays used for quantitative PCR
Gene Exon-exon
boundary
Cat. number
Cyclin-dependent kinase inhibitor
1A CDKN1A/P21
2-3 Hs00355782_m1
Tumor protein p53 TP53/p53 9-10 Hs00153349_m1
Polymerase (RNA) II (DNA directed)
polypeptide A POLR2A
1-2 Hs00172187_m1
All primers/probes were purchased from Applied Biosystems.
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were irradiated on the plate with 2 or 8 Gy using a
Philips RT 100 X-ray machine with an acceleration
voltage of 100 kV.
mRNA extraction
Irradiated cells were lysed by addition of 360 μl Buffer
MRL (Qiagen)/well directly to the 24-well plates. mRNA
was extracted and purified with a MagAttract Direct
mRNA M48 Kit with oligo(dT) covered magnetic beads
on a GenoM-48 Robotic Workstation (Qiagen). Standard
settings for mRNA extraction were used with 100 μl
elution volumes.
cDNA synthesis
10 μl of mRNA was used as template for cDNA synthesis
in a 20 μl reaction. The reaction buffer consisted of First
Strand Buffer ×1, 10 mM dithiothretiol (DTT) and 5 U/μl
SuperScriptTM II Reverse Transcriptase (Invitrogen) and 1
U/μl Protector RNase Inhibitor, 20 pmole/μl HexanucleotideMix and 0.25 mM of each dNTP, Li-Salt (Roche Diagnos-
tics). The RT reaction was performed on a PTC-200 Peltier
Thermal Cycler (MJ Research) at 22°C for 10 min, 42°C for
45 min and 99°C for 3 min.
Quantitative PCR
TaqMan® Gene Expression Assays for p53, p21 and
POLR2a (Pol II) were purchased from Applied Biosys-
tems (Table 2). All primer products span exon–exon
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reactions were performed using 5 μl of cDNA in Micro-
Amp™ 96-well optical microtiter plates on a 7900HT
Fast QPCR System in TaqMan® Fast Universal PCR
Master Mix (Applied Biosystems) according to protocol
(total volume 25 μl). cDNA was diluted 10 times prior
to qPCR and all samples were run in duplicate. PCR
results were analyzed with SDS 2.3 software (Applied
Biosystems) and relative quantity was determined using
the ΔΔCT Method [10], with DMSO-treated cells as
calibrator and POLR2A as endogenous reference.
Gamma-H2AX staining
Gamma-H2AX detection was performed essentially as
previously described [11]. H2AX is a form of Histone 2A
that is phosphorylated upon DNA double strand break
induction (gamma-H2AX) and can thus be used as a
measure of DNA double strand breaks after irradiation.
HUVEC cells were seeded in 12-well plates 24 h pre-
irradiation. In brief, after irradiation the cells were
incubated at 37°C for 30 min to allow complete H2AX
phosphorylation and then kept on ice during the whole
procedure to avoid phosphatase activity. After trypsination
and harvest, the cells were incubated with Block-9 staining
buffer containing anti-phospho-H2AX FITC-conjugated
antibody (Millipore) and Vybrant Dye Cycle Violet stain
(Invitrogen, Molecular Probes) for 3 h on ice. The in-
crease in phosphorylated H2AX was then detected on a
FACSAria flow cytometer (BD Biosciences). Excitation
wavelengths were 488 nm/405 nm respectively and emis-
sion was detected with filter/bandpass 450/40 for FITC
and 530/30 for Vybrant Dye Cycle Violet Stain.
EdU staining
HUVEC cells were seeded out in 24-well plates 24 h
pre-radiation. After irradiation, the cells were harves-
ted by trypsination, diluted 1:8 and reseeded into 6-well
plates. After growing for 48 h, EdU was added to the
cells at a concentration of 10 μM. EdU assay, as a
measure of cellular proliferation, was performed es-
sentially as earlier described (Ref: Flow cytometry methods
for DNA-damage induced clonogenic cell death calibrated
to the colony forming assay, Yue Gao, Pegah Johansson,
Aida Muslimovic and Ola Hammarsten, submitted manu-
script), using a Click-iT® EdU Alexa Fluor® 488 Imaging
Kit (Invitrogen). In brief, after 16 h incubation with
EdU, the cells were washed with PBS and harvested
by trypsination. After a 0.1% BSA/PBS wash, the cells
were fixed for 15 min. The cells were washed again
in BSA/PBS and then permeabilized for 30 min. After
another wash with BSA/PBS, the cells were incubated
in staining buffer according to protocol for 30 min,kept from light. After a final wash in 1× component
E, the cells were incubated with Ribonuclease A for
30 min. Before Analysis on a FACSAria flow cytometer
(BD Biosciences), the cells were diluted in 300 μl
BSA/PBS.
Data analysis
Statistical analysis was carried out using ANOVA
followed by Tukey’s post hoc tests (GraphPad 4.0
Software, San Diego, CA). Significance was assumed
for p value less than 0.05. Sigmoidal best fit curve
generated with sigmoidal fit equation at http://zunzun.com,
using the Hill with offset equation: ax^b/(c^b + x^b) +
Offset.
Results and discussion
In an effort to derive RNAi-competent sequences from a
target gene we prepared an shRNA-expressing retroviral
library based on random 21-26 nt sequences (~250 se-
quences) derived from the human Axl gene sequence, a
receptor tyrosine kinase frequently expressed in human
cancer and correlated with poor overall survival [12].
The shRNA library was transduced into MDA-MB-231
breast carcinoma cells; individual cells with reduced Axl
cell surface expression were isolated by FACS and the
cognate shRNA sequences identified by PCR and deep
sequencing. We noted that each sequence displayed a
unique, reproducible gene knockdown level that was
not predictable by analysis in available RNAi sequence
algorithms (Additional file 3: Figure S3). Collectively,
these Axl-targeting shRNAs comprised an epi-allelic
hypomorphic series in MDA-MB-231 cells that vali-
dated the role of Axl in metastasis in vitro and
in vivo [2].
Based on these results we developed an approach to
rapidly identify functional shRNA sequences from high-
coverage gene specific shRNA libraries to enable epi-allelic
hypomorphic analysis of putative therapeutic targets [1].
The natural fluctuation in protein levels routinely dis-
played by flow cytometric analysis can be modeled by nor-
mal probability distributions [13]. Hence, a cell population
expressing an shRNA library against a target gene can be
represented as a continuous distribution comprising mul-
tiple samples. The probability that a cell will be found
below a given threshold is proportional to the difference
in target gene expression means of the hypomorphic and
wild type cell populations (Additional file 4: Figure S4).
Importantly, this leads to the prediction that the number
of cells expressing a specific shRNA found below this
threshold will be related to the potency of the shRNA.
This implies that the frequency of different shRNA
sequences recovered from a sorted cell population should
be proportional to their knockdown levels.
Figure 1 The CellSelectRNAi approach. (a) CellSelectRNAi principle. HL60 reporter cells are transduced with a library of candidate shRNAs
targeting gene of interest. Each cell is interrogated by flow cytometry; cells with reduced reporter levels are sorted for subsequent PCR and
shRNA sequence identification by 454 deep sequencing. Sequences are plotted by frequency representation in the sorted population. (b)
Schematic of the CellSelectRNAi system. The RNAi reporter comprises a destabilized GFP (dsGFP), with the untranslated target gene cloned
downstream of a translational stop codon (*). In the scenario on the left, a RISC complex is loaded with an effective shRNA that will bind to the
target mRNA sequence in the reporter mRNA and initiate mRNA cleavage and prevention of dsGFP reporter translation. In the scenario on the
right, the RISC complex is loaded with an ineffective shRNA that is unable to bind the target mRNA. The efficiency of each shRNA is proportional
to the amount of dsGFP in the cell, and can be measured by flow cytometry. (c) RNAi reporter correlates with endogeneous gene expression.
Flow cytometric analysis showing the level of RNAi reporter and endogeneous Axl cell surface protein in each epi-allelic MDA-MB-231 cell line
demonstrates a linear relationship between RNAi reporter intensity and Axl protein stained with Axl antibody. Each point on the graph represents
the geometric mean and the graph is representative of four individual experiments. The error bars represent 95% confidence-limit on the mean.
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Figure 2 Generation of an shp53 epi-allelic series. (a) HL60 p53-RNAi reporter cell line. A HL60 cell line was transduced with p53-RNAi
reporter construct and a single cell-derived clone was isolated by FACS, expanded and reanalysed for optimal (GFP) reporter expression by flow
cytometry. (b) HL60 p53-RNAi reporter cells transduced with shp53 library show a population with reduced RNAi reporter expression. HL60
p53-RNAi reporter cells were transduced with a library of candidate p53 shRNA or control shRNA (shLuc). All cells were monitored by FACS and
cells with reporter levels within the GFPlow/RFP + gate (box) were sorted. (c) Functionally selected shRNA sequence frequency profile. Sequences
retrieved from the 454 deep sequencing were tested to determine whether they encoded a hairpin structure and clustered into groups of
near-identical sequences, and plotted by frequency. (d) Generalized linear model (GLM) fit of shRNA sequence frequency versus RNAi reporter
level reveals a statistical relationship. Representative shp53-sequences were recloned, transduced into HL60 p53-RNAi reporter cells and analyzed
by flow cytometry. A generalized linear model (GLM) with a log link function (‘log(frequency) ~ 1 + knockdown’) and Poisson distribution was
applied to model the shRNA frequency versus RNAi reporter fluorescence intensity, generating estimated coefficients listed in Table 2, Additional
file 4: Figure S4. The GLM model shows an exponential relationship between the observed shRNA frequency and measured RNAi reporter at a
significance level of α = 0.05 (p ≈ 0). The reporter intensity data represents the mean of three independent experiments. (e) HUVE cells transduced
with different shp53 clones generates an epi-allelic series. Transduced HUVE cells expressing different shp53 shRNA sequences show graded p53
expression levels as measured by relative quantification of Western blot versus mRNA levels.
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screening approach to identify functional RNAi-triggers
(CellSelectRNAi; Figure 1a). Libraries of candidate retrovi-
rally expressed shRNAs are transduced into a population
of host cells stably expressing a dedicated RNAi-GFP
reporter and sorted for target gene knockdown by FACS.
shRNA sequences are identified from the sorted cells
by PCR and deep sequencing, and assembled into a fre-
quency profile. The frequency of a given shRNA should
correlate with knockdown efficiency. The RNAi-GFP
reporter, comprising an open reading frame encoding a
destabilized GFP [14], fused to hygromycin phosphotrans-
ferase (hpt) together with the untranslated target cDNA
sequence serving as a 3′-UTR may be used to identify
functional shRNAs for any gene (Figure 1b). To validate
this RNAi-reporter system we prepared an Axl RNAi-
reporter MDA-MB-231 cell line that was transduced sep-
arately with four different Axl shRNAs (shAxl2, shAxl280,
shAxl279, shAxl278) in addition to a control shRNA
targeting luciferase (shLuc). These five cell lines were
simultaneously analyzed for reporter and endogenous Axl
surface receptor protein levels by multicolor flow cyto-
metry. Axl RNAi-reporter GFP fluorescence correlated
strongly (R2 = 0.9931) with endogeneous surface Axl re-
ceptor protein (Figure 1c) in the epi-allelic MDA-MB-231
cell series.
To evaluate the CellSelectRNAi approach, we generated
p53 RNAi-reporter expressing HL60 cells. Flow cyto-
metric analysis of the HL60/p53-RNAi reporter cell line
displayed dsGFP fluorescence with a mean fluorescence
intensity of 1721 and coefficient of variation (CV) of 36.8
(Figure 2a). A high coverage p53 shRNA library was
prepared using a novel cloning approach where random
sequences derived from the p53 mRNA sequence are
converted into a form that encodes a hairpin structure
and cloned into a U6 promoter cassette within a self-
inactivating retroviral vector (Additional file 5: Figure S5).The p53 shRNA library (approximately 100 unique sequences)
was transduced into the HL60/p53-RNAi reporter cell line
and analyzed by FACS (Figure 2b). A low transduction
rate (~10%) was used to favor single retroviral integrations
per cell. A sorting gate was set at 2 standard deviations
from the mean of the wild type population and HL60/
p53-RNAi reporter cells carrying p53-targeting shRNAs
(RFP+) within the sorting gate were isolated (Figure 2b).
1800 sorting events were collected and proviral PCR amp-
lification was conducted to generate a ~280 bp product
that was analyzed by massively parallel pyrosequencing.
The resulting 14790 shRNA sequences, of which 32 were
p53 shRNA (Additional file 6: Figure S6) were rank
ordered by frequency to generate a distribution plot
(Figure 2c). Eight p53 shRNA sequences representing
high, intermediate and low frequency levels were recloned
and reintroduced into the HL60/p53-RNAi reporter cell
line and monitored for reporter knockdown by flow
cytometry. As predicted by the continuous distribution
model, the shRNA sequence frequency derived from the
sorted population showed a clear statistical relationship
with the reporter intensity (Figure 2d). The most prevalent
shRNA sequences identified by the CellSelectRNAi ap-
proach were the most potent also when measured at
endogenous protein level and mRNA level (Figure 2e,
Additional file 7: Figure S7). These results demonstrate
accurate prediction of effective shRNA sequences by the
CellSelectRNAi approach. Importantly, the most potent
p53 shRNAs identified in the library screen are not
predicted by available RNAi sequence algorithms [15]
(Additional file 3: Figure S3).
We conducted epi-allelic hypomorphic analysis using
selected p53-targeting shRNAs to determine the thresh-
old of p53-dependent responses to ionizing radiation in
primary human endothelial cells. p53 is a transcription
factor involved in the DNA damage response. p53 acti-
vation by DNA damage, such as upon ionizing radiation,
Figure 3 (See legend on next page.)
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Figure 3 Epi-allelic hypomorphic analysis to determine the threshold of p53-dependent responses to ionizing radiation. (a) Non-linear
correlation between p53 and p21 mRNA levels in p53 epi-allelic primary human endothelial cells. Graded p53 knockdown in human umbilical
cord endothelial cells (HUVEC) with shp53-3, shp53-10 shp53-13 or negative control (shLuc) (left panel) corresponded to a non-linear reduction in
p21 gene expression (right panel). Data represent the mean ± SD of three (p53) and five (p21) measurements representative for two independent
experiments relative to control cells (set as 100%). Statistical analysis was carried out using ANOVA followed by Tukey’s post hoc tests, *P < 0,05.
(b) Non-linear correlation between p53 and p21 mRNA levels in p53 epi-allelic primary human endothelial cells after irradiation. Irradiation of
p53-epi-allelic HUVEC with 2 or 8 Gy did not affect p53 mRNA levels but increased p21 mRNA expression in a non-linear, p53-dependent manner.
The data represents the mean of duplicate samples ± range. (c) Ionizing radiation induced H2AX phosphorylation in p53 epi-allelic primary
human endothelial cells. H2AX phosphorylation, a measure of DNA double strand break induction, in HUVEC, correlates with greater p53
knockdown. The data represents the mean of duplicate samples ± range. (d) Cell proliferation in p53 epi-allelic primary human endothelial cells
with shRNA against p53 after irradiation. The number of EdU positive p53-epi-allelic HUVEC following ionizing radiation, as a measure of cell
division, increases with p53 knockdown efficiency. The data represents the mean of duplicate samples ± range. (e) Dose response relationship
between p53-levels and radiation-induced p21 activation by epi-allelic analysis. Ionizing radiation-induced p21 activation displays a sigmoidal
dose-dependency on p53 gene expression.
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sponse genes. p21 is an example of a p53-regulated gene
which is induced following ionizing radiation and was
used here to assess the effects of shRNA-mediated
knockdown on p53 activity [16]. As shown in Figure 3a-b,
graded p53 knockdown in primary human endothelial
cells resulted in a non-linear attenuation of p21-activation
following ionizing radiation. Radiation-induced double-
strand break repair (histone H2AX phosphorylation) and
DNA synthesis were similarly diminished in endothelial
cells with less than 50% of wild type p53 expression levels
(Figure 3c-d). Intriguingly, the observed dose-dependency
of ionizing radiation-induced p21-activation on p53 gene
expression levels fits a sigmoidal dose response model
with an apparent IC50 around 50% p53-expression,
the expected gene dosage of a p53+/- heterozygote
(Figure 3e).
Conclusion
These results demonstrate that flow cytometric selection
of RNAi knockdown cells combined with deep sequence
analysis can be used to identify multiple shRNA se-
quences that reduce target gene expression to predeter-
mined levels. Perhaps surprisingly, the most potent
functionally-selected sequences do not follow widely
used RNAi scoring algorithms and are therefore not
represented in current RNAi collections. The ability to
readily generate several shRNAs per gene carries signifi-
cant advantages. In addition to obviating the influence of
“off-target” effects [17,18], a set of shRNAs with differing
silencing potentials provides an epi-allelic series of hypo-
morphs, a genetic dose-response, that can uniquely
relate gene expression to functional response thresh-
olds and improve target-phenotype correlations [1,2].
Epi-allelic analysis highlights the “robustness” that
buffers perturbations on biological systems and delin-
eates drug target inhibition profiles for therapeutic
translation [19].Additional files
Additional file 1: Figure S1. Retroviral vector L101 complete sequence.
Additional file 2: Figure S2. (A) L267 cloning vector with details of
polylinker. Hairpins are expressed under the control of a modified U6
promoter, and cloned between the NaeI at the transcription start and the
XcmI at the transcription terminator. PacI/HindIII restriction enzyme sites
to facilitate cloning of the completed cassette into the final vector. (B)
Structure of Hairpin Oligo DK540, including EcoP15I site (blue), GsuI sites
(red) and a half-PvuII site (green). The loop sequence present in the
completed hairpin cassette is in yellow. (C) Hairpin Oligo DK540 ligated
to each end of a short fragment of p53. Digestion with EcoP13I releases
two hairpin-tagged sequences which are then blunt-ended with Klenow
fragment and dephosphorylated. (D) NaeI/XcmI-digested vector is ligated
to haripin-tagged sequences. Because the haripin tag lacks a 5′ phosphate,
the ligation product will have a ‘nick’ in the DNA phosphate backbone as
indicated. DNA polymerisation from this nick using a strand-displacing
polymerase opens out the hairpin into dsDNA. (E) Subsequent digestion
with GsuI and recircularisation shortens the hairpin loop.
Additional file 3: Figure S3. Functionally selected shRNA sequences
fail in RNAi scoring algorithms. Hairpin sequences from this study that
gave good knockdown efficiency (actual efficiency) were scored with
eight different RNAi scoring algorithms using the i-Score server
(http://www.med.nagoya-u.ac.jp/neurogenetics/i_Score/i_score.html). Bold
italic: score within top 100 for gene. Glt: guide strand-loop-template strand
orientation. Tlg: template strand-loop-guide strand orientation.
Additional file 4: Figure S4. Predictions of knock-out effect.
Additional file 5: Figure S5. Schematic drawing of the hairpin
expression cassette. shRNAs are produced from the U6/tethracyclin-
inducible (TetO) promoter. The U6 promoter can transcribe short RNAs
by RNA Polymerase III. This expression cassette also contains genes
coding for mCherry and Puromycine separated by a linker encoding the 2A
self-cleaving sequence under the control of the EF1a promoter.
Abbreviations: pA, polyadenylation signal; uro, puromycin; Ψ, packaging
signal; T, terminator.
Additional file 6: Figure S6. Sequences that have been
scored as hairpins in screen. Lowercase letters signify hairpin loop.
Additional file 7: Figure S7. Epiallelic HUVE cells comprising
p53-targeting shRNA’s show graded p53 expression levels by
immunoblotting.Abbreviations
dsGFP: Destabilized GFP; FACS: Fluorescence activated cell sorter; GFP: Green
fluorescent protein; HUVEC: Human umbilical vein endothelial cell; LTR: Long
terminal repeat; nt: Nucleotides; RFP: Red fluorescent protein; RNAi: RNA
interference; shRNA: Short hairpin RNA.
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